Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common stock, par value $0.001 per share (the "Common Stock")
-
Shares outstanding
-
139M
-
Number of holders
-
286
-
Total 13F shares, excl. options
-
64.8M
-
Shares change
-
-4.17M
-
Total reported value, excl. options
-
$4.11B
-
Value change
-
-$251M
-
Put/Call ratio
-
1.05
-
Number of buys
-
157
-
Number of sells
-
-102
-
Price
-
$63.43
Significant Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) as of Q4 2019
328 filings reported holding ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") as of Q4 2019.
ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) has 286 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64.8M shares
of 139M outstanding shares and own 46.71% of the company stock.
Largest 10 shareholders include BlackRock Inc. (12.4M shares), VANGUARD GROUP INC (9.8M shares), STATE STREET CORP (4.12M shares), Invesco Ltd. (3.29M shares), Johnson & Johnson Innovation - JJDC, Inc. (3.26M shares), FIRST MANHATTAN CO (2.07M shares), FMR LLC (1.88M shares), NORTHERN TRUST CORP (1.55M shares), GEODE CAPITAL MANAGEMENT, LLC (1.43M shares), and FIERA CAPITAL CORP (1.37M shares).
This table shows the top 286 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.